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Abstract
Background: Type 2 Diabetes Mellitus (T2DM) is a non insulin dependent, complex trait disease
that develops due to genetic predisposition and environmental factors. The advanced stage in type
2 diabetes mellitus leads to several micro and macro vascular complications like nephropathy,
neuropathy, retinopathy, heart related problems etc. Studies performed on the genetics,
biochemistry and molecular biology of this disease to understand the pathophysiology of type 2
diabetes mellitus has led to the generation of a surfeit of data on candidate genes and related
aspects. The research is highly progressive towards defining the exact etiology of this disease.
Results: T2D-Db (Type 2 diabetes Database) is a comprehensive web resource, which provides
integrated and curated information on almost all known molecular components involved in the
pathogenesis of type 2 diabetes mellitus in the three widely studied mammals namely human, mouse
and rat. Information on candidate genes, SNPs (Single Nucleotide Polymorphism) in candidate
genes or candidate regions, genome wide association studies (GWA), tissue specific gene
expression patterns, EST (Expressed Sequence Tag) data, expression information from microarray
data, pathways, protein-protein interactions and disease associated risk factors or complications
have been structured in this on line resource.
Conclusion: Information available in T2D-Db provides an integrated platform for the better
molecular level understanding of type 2 diabetes mellitus and its pathogenesis. Importantly, the
resource facilitates graphical presentation of the gene/genome wide map of SNP markers and
protein-protein interaction networks, besides providing the heat map diagram of the selected
gene(s) in an organism across microarray expression experiments from either single or multiple
studies. These features aid to the data interpretation in an integrative way. T2D-Db is to our
knowledge the first publicly available resource that can cater to the needs of researchers working
on different aspects of type 2 diabetes mellitus.
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Background
T2DM previously known as non-insulin dependent diabe-
tes mellitus (NIDDM) is a multifactorial and genetically
heterogeneous disease caused by impairment in both
insulin secretion and insulin action [1-5]. A total of 180
million people are affected and the prevalence of T2DM is
continuously rising throughout the world. The number
affected is estimated to be more than double by 2030 [6].
The primary characteristics of this disease include insulin
resistance, relative insulin deficiency and hyperglycemia.
The disease develops due to genetic predisposition and
environmental factors such as improper food-habits,
obesity, sedentary lifestyle etc. Insulin deficiency is a con-
sequence of hyperglycemia, it causes impaired insulin-
mediated glucose uptake from muscle, increased hepatic
glucose production and also an increase in the mobiliza-
tion of free fatty acids from adipose tissue, decreased
mitochondrial biogenesis, and reduced ATP biosynthesis
etc. [7-10]. Studies indicate that insulin resistance alone
does not result in T2DM unless there is an β-cell inability
to compensate for the insulin resistance with appropriate
hyperinsulinemia [9,11]. β-cell dysfunction is character-
ized by the impairment of insulin secretion [2,12].
Increased levels of non-esterified fatty acid (NEFA), glyc-
erol, Tumor Necrosis Factor-α (TNF-α), cytokines in the
blood plasma and the other environmental and genetic
risk factors adversely affect the insulin signaling cascade
[13-15]. A reduced level of adiponectin, an insulin sensi-
tizing hormone from adipocytes, is also a predictive signal
for this disease [16,17]. Obesity is associated with insulin
resistance and it is reported to be a major risk factor
responsible for the development of T2DM [15,18].
In terms of correlating genetic predisposition and T2DM,
multiple chromosomal regions have been reported to har-
bor susceptibility genes [3,5,19]. Some common gene var-
iants, reported to be consistently associated with T2DM
include those of calpain 10 (CAPN10) [20], PPAR-γ coac-
tivator 1 (PGC1) [21], Pro12Ala PPAR-γ (PPARG) [22],
Glu23Lys potassium inward rectifying channel (KCNJ11)
[23], Hepatocyte nuclear factor-4 alpha (HNF4α) [24,25],
the glucose transporter (GLUT2) [26], transcription factor
7-like 2 gene (TCF7L2) [27] and retinol binding protein
(RBP4) [28].
The progress of research on etiology, genetic predisposi-
tion, role of environmental and other risk factors, charac-
terization of candidate genes and other molecular,
genetics and biochemical parameters has led to the gener-
ation of voluminous data. Hence, availability of all data-
sets as an integrated resource would be useful in acquiring
a better understanding of pathophysiology of the disease.
Considering the impact of such information in facilitating
diabetes research and drug design, and with the aim of
providing easy access to the large and increasing volume
of data, we have developed a comprehensive web resource
on T2DM and named it as T2D-Db. This compliments
another publicly available resource on Type 1 diabetes
(T1Dbase) on diabetes research [29].
T2D-Db provides an user-friendly platform with exhaus-
tive search options for the retrieval of all reported infor-
mation on candidate genes in human, mouse and rat. The
database has been organised into candidate genes, gene
expression data, pathways, protein-protein interaction,
SNP marker data and risk factors/complications. It facili-
tates a graphical as well as a tabular display of SNP mark-
ers in a gene/genome-wide map for a user selected
chromosomal segment in a selected organism. Further-
more, T2D-Db provides tabular and heat map presenta-
tion [30] of the microarray expression data of selected
gene(s) in an organism across multiple experiments. Net-
work visualization and analysis for interaction data has
also been made possible through Cytoscape web-launch
[31]. Every module of the database has been linked with
other relevant external resources and the literature for fur-
ther information on the selected component. The data-
base will be updated periodically with enhanced features
and new candidate genes as and when they are reported.
We also urge the diabetes research community to submit
data to keep this public platform updated. Finally, T2D-
Db with the aforesaid features will be an extremely useful
resource in analyzing and correlating the available
research data on the molecular basis of type 2 diabetes.
Motivation for T2D-Db
The development of T2D-Db has been motivated by the
intense impact of this disease on human health. The ever-
increasing complications of T2DM have led researchers to
do intensive studies on this disease. Continuous research
efforts in this field have led to the accumulation of huge
amount of data. Further research on this complex and
multifactor/polygenic type 2 diabetes requires collation of
all the known candidate genes and related information to
understand the complete molecular pathophysiology of
the disease. Though, the candidate gene/region and other
molecular data is available through different databases, it
is very inconvenient to study the diasese by searching the
scattered information. The entire information has been
integrated in T2D-Db. The user can search and obtain the
data as a desired table/graphical display quickly and effi-
ciently from a single resource. The data organization and
tool features provide much more meaning to the data
than the data available from individual resources. An inte-
grated comparison and analysis of the candidate genes
will help a researcher to assess the importance of these
genes in the disease that might further give an insight for
designing the newer and powerful drugs against this dis-
ease.BMC Genomics 2008, 9:320 http://www.biomedcentral.com/1471-2164/9/320
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The user-friendly and freely accessible T2D-Db is expected
to serve the research community with a huge amount of
information to accelerate the progress of work in this
field.
Database implementation
Database contents
The candidate gene data has been manually curated from
the Pubmed literature. We could extract 159, 59, and 36
empirically defined candidate genes for human, mouse
and rat respectively. The annotation based searches for
these reported genes were made from NCBI Entrez gene
database [32]. Supplementary data for each candidate
gene were also taken from OMIM [33], MGI [34], RGD
[35], and Ensembl [36] databases. The nucleotide
sequence of each candidate gene was downloaded from
NCBI nucleotide database. The following criteria have
been used to search the candidate genes from Medline lit-
erature:
i. PubMed and GoPubMed databases have been searched
thoroughly giving different keywords related to the dis-
ease like: Type 2 diabetes, non-insulin dependent diabetes
mellitus and insulin resistance etc.
ii. After the careful extensive reading of the research arti-
cle, we identify the candidate genes for diabetes and asso-
ciated risk factors and complications. The data is further
validated twice by senior curators and then included in
T2D-Db.
iii. OMIIM (for human gene), MGI (for mouse gene),
RGD (for rat gene) and Ensembl databases have been used
to cross validate the function of each gene gene.
Gene orthologs of each candidate gene for each organism
were searched and collected from NCBI Entrez gene data-
base (Human-NCBI 36.2, Mouse-NCBI M37.1, Rat-RGSC
v3.4) [32]. Information on putative homologs of candi-
date genes in different organisms, and transcript
sequences from the same transcription locus were col-
lected from NCBI Homologene (Release 61) [37] and
Unigene databases (Build#210) [38] respectively. Tran-
script information of candidate genes was taken from the
database of transcripts (DoTS) of EPConDb (version 4.1)
[39].
In addition to gene related information, we included gene
ontology based information such as biological function,
process and molecular component of candidate genes
from Gene Ontology database, Amigo (Release 2008-04-
10) [40]. In order to be more comprehensive, data under
other important categories have also been included. For
instance, information regarding biological pathways
involving candidate genes was retrieved from KEGG
(Release 43.0) [41], Biocarta [42] and Reactome (Version
22) [43] databases. Protein-protein interaction data for
each candidate gene of human, mouse and rat was col-
lected from the APID (Release July 2007) [44] and PIP
[45] databases. The SNP markers corresponding to each
susceptible gene and chromosomal segments have been
downloaded from dbSNP (Build 126) [46]. EST informa-
tion was extracted from dbEST (Release 041108) [47]. Tis-
sue specific gene expression data was downloaded from
GNF SymAtlas (Version 1.2.4) [48]. The normalized
microarray expression data has been taken from NCBI
Gene Expression Omnibus (GEO database) [49] and rela-
tional tables were generated for all the experimental data.
The risk factor/complications data is collected as follows:
The information on factors increasing the risk/complica-
tions of this disease has been collected through the
Medline literature search. Following this, each risk factor
is searched thoroughly for its association with T2D and
the responsible candidate genes have been collected, vali-
dated and organized in T2D-Db.
Value addition and data integration in T2D-Db
The candidate gene/candidate region data has been col-
lected and annotated with all reported molecular infor-
mation on these genes and systematically organized in
T2D-Db. Besides, the seamless organization of molecular
data for each candidate gene, this platform also facilitates
an online systems biology analysis of the selected candi-
date genes and their interacting partners. Simultaneously,
it caters genome wide map display of SNP, Genome Wide
Association (GWA) and EST data along with the informa-
tion on associated genes in a selected genomic stretch.
One can also visualize the expression patterns of candi-
date genes and other important genes from microarray
expression datasets through an expression viewer. It also
supports information on risk factors and complications of
type 2 diabetes. T2D-Db will support the continuous need
of updated information on above mentioned molecular
data and other important facts associated with this dis-
ease.
Database design and organization
The web interface of T2D-Db has been developed using
HTML, DHTML and Javascript. All data in the database
have been stored in MySQL tables. CGI-Perl has been used
as an interface layer between the front and back ends of
T2D-Db. CGI-Perl scripts process all the queries from the
user by fetching the data from the database and displaying
it on the webpage after proper formatting of the results.
FASTA formatted nucleotide sequences of genes have been
stored in flat files, which can be downloaded as well.
Additional file 1 describes the data flow through the data-
base application. The database has been integrated withBMC Genomics 2008, 9:320 http://www.biomedcentral.com/1471-2164/9/320
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the following three tools to facilitate the meaningful
graphical representation of the data.
1) Microarray expression viewer
The Microarray Expression Viewer is a Java based applica-
tion, created to provide a visual display of gene expression
data for a set of selected genes across a set of selected
experimental studies. Java Web Start is used for launching
the application on the user's machine. The .jnlp file for
launching the application is created dynamically upon
querying the search option 'heat map-view'. All the stud-
ies, experiments and the corresponding gene expression
values are collected into a text file, which is an input to the
viewer application. The heat map generated can be
explained as follows:
(i) The Heat Map shows the labelled samples (both con-
trols and diseased ones) and the expression of genes. (ii)
It displays the intensity level for each gene as red, green or
yellow spot. A red spot indicates increased expression of a
particular gene in the diseased samples. A green spot indi-
cates normal expression and a yellow spot indicates no
change in the expression levels between the controls and
the diseased samples.
2) Protein-protein interaction map
Cytoscape 2.5.1 [31], a publicly available Java-based
molecular interaction network visualization tool has been
integrated with T2D-Db to customize and facilitate pro-
tein-protein interaction network analysis. The network for
a selected gene will be generated and launched on Cyto-
scape panel on the user's machine using the Java web start
technology. The data sources for network analysis have
been procured from APID and PIP databases. The user can
select either of the two data sources to view the interaction
network for a particular gene.
3) SNP Marker map
The 'SNP map' generates a dynamic map displaying SNP
markers and the corresponding genes in selected chromo-
somal regions of specific chromosomes in any of the three
organisms. The map shows the names of the genes and
SNPs on mouse over. Names are further externally linked
to Entrez gene database and dbSNP respectively. MySQL
tables have been created for both SNP marker and gene
data, which in turn are relationally linked to each other.
Perl programs using the GD module generate the map
view and allow the user to view SNP markers in a selected
chromosomal segment on the map. Besides the display of
candidate gene specific SNP markers from dbSNP, SNP
map displays both tables and graphical view of all T2D
associated markers from dbSNP and Welcome Trust Case
Control Consortium (WTCCC) in a selected human
genomic stretch. The SNP markers have been provided
with the external links to the HapMap database (50).
4) EST Marker map
EST information has been provided for a better under-
standing on the expression behavior of particular candi-
date genes. T2D-Db provides an EST map tool that maps
and displays ESTs and the associated genes in the selected
regions on specific chromosomes. These data is further
externally linked to NCBI dbEST and Entrez gene data-
bases respectively.
5) T2D Gemone-wide association studies
Genome wide association study shows the genetic varia-
tions associated with a particular disease. The GWA stud-
ies on diabetic vs control subjects have been collected
from WTCCC (51). The data is displayed as tables and
map at a genome wide scale. T2D-Db also provides an
external link to each candidate gene in Genetic Associa-
tion Database (GAD).
Results and Discussion
All information related to the reported candidate genes of
T2DM is available in T2D-Db. A variety of search options
have been created, which provide easy and quick access to
all the modules of the database. The search options are
self explanatory and highly specific for each section of the
database. Some important features of the database are
listed below:
a) T2D-Db provides both compact and detailed informa-
tion on each candidate gene. The compact view section
gives a precise description about the gene name, gene
locus, and gene ID and gene symbol hyperlinked with
NCBI Gene and T2D-Db Gene page respectively. The
detailed view provides gene summary, OMIM ID and
Ensembl ID with external links to their respective data-
bases and literature sources. The gene summary includes
gene name, gene symbol, gene aliases, a precise descrip-
tion, gene locus, chromosomal number and the related
literature. It also includes data under several different cat-
egories, which can be expanded further to view or save in
detail (Figure 1). Candidate genes can be searched
through key words, organism selection and also browsed
alphabetically for human, mouse and rat. There are other
supplementary search modules on candidate gene i.e,
Gene ontology, Orthologs, Homologene, Unigene, Tran-
scripts and so on. Figure 1(A-C) exemplifies the schematic
flow of information when a query on specific candidate
gene is submitted.
b) A quick search option has been provided to ease access
to all the information available on candidate genes of
human, mouse or rat. The user can enter any query and
select the relevant information such as Candidate genes,
Markers, Pathways and Risk factors/complications from a
dropdown menu to search the database.BMC Genomics 2008, 9:320 http://www.biomedcentral.com/1471-2164/9/320
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Querying a candidate gene through simple search option (A-C) Figure 1
Querying a candidate gene through simple search option (A-C). (A) Querying a candidate gene search page by using 
gene name as keyword. (B) Candidate gene result page for the keyword 'leptin'. Options are provided to view the compact and 
detailed information for the selected genes in this page. (C) The detailed gene information page, which is obtained by clicking 
on 'Gene symbol' in the previous page. This page provides all associated information for the selected gene.
(A)
(B)
(C)BMC Genomics 2008, 9:320 http://www.biomedcentral.com/1471-2164/9/320
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c) The gene symbol in every section has a link to a T2D-
Db result page, which contains exhaustive data for the
selected gene such as candidate gene information, gene
aliases, orthologs, pathways, protein-protein interaction
data, gene ontology, SNP markers, gene expression data,
literature and links to the respective external databases.
d) The Gene Expression Search section provides tissue
specific gene expression data, and all the available EST
information for each gene with external links to NCBI
dbEST. Additionally, expression values for each gene from
single or multiple microarray datasets can be curated
through this database. The microarray expression data
search option provides an opportunity to the user to select
a set of specific experiments, and analyze and visualize the
results comparatively to formulate their own hypothesis.
The gene expression pattern of a set of user selected genes
across single or multiple experiments in an organism can
also be visualized as a heat map. In addition to the selec-
tion of candidate genes, the user can add other gene(s) of
interest to obtain a collective view of the expression pat-
tern. Figure 2 describes the flow of query processing to
extract microarray expression data of candidate gene(s)
across single or multiple experiments in Human as an
illustration.
e) Pathway information on candidate genes participating
in different biological pathways is provided with their
names and IDs from Biocarta, KEGG and Reactome data-
bases.
f) SNP markers found in a specific candidate region of a
chromosome in a selected organism can be viewed as an
'SNP map'. This marker map displays the names, chromo-
somal localization of genes and corresponding SNP mark-
ers in a chromosome-wide map. It also facilitates access to
the T2D-Db candidate gene page and external links to the
UCSC genome browser and NCBI Gene. Figure 3 displays
the processing of a sample query to obtain a SNP map in
a user selected chromosomal region.
g) Protein-protein interaction data can be accessed for
each candidate gene through data search as well as inter-
action map options. Cytoscape, a network visualization
and analysis software has been integrated into T2D-Db,
which allows the user to view the protein interactors as a
network. This option is available for viewing the protein-
protein interaction data for each candidate gene. Figure 4
displays protein interactors from APID and PIP database
for a candidate gene. The interaction data can be analyzed
and functionally elaborated with the help of interaction
network in Cytoscape.
h) A complete list of genes involved in T2DM-associated
risk factors/complications has been provided in the 'Risk
Factors/Complications' section of the database. Search
options similar to that of querying candidate gene infor-
mation have also been provided in this module.
i) The candidate genes and candidate regions have been
collected through careful and intensive literature search.
Depending on this information all other data subsets have
been collected from other external databases as well as
from relevant research articles. The statistics for each data
subset provides the information of total number of the
entries under each category. The statistics page points out
the total number of candidate genes (254 genes) and
regions (25, specifically for human), their unigene cluster
IDs (275), homologene IDs (251), transcript IDs (700),
gene ontology terms (1,615), markers like SNPs (54,692)
and ESTs (98,727), the expression values obtained from
microarray studies (16,946), biochemical pathways
(989), tissue-specific expressions (184), interacting pro-
teins (5961) and the research articles (7,302) read and
finally used to validate the authenticity of data and related
information. It also gives the total number of risk factors
(6) and complications (7) associated with type 2 diabetes.
This page also facilitates a hyperlink from each entry to
the corresponding page, which displays more detailed
information. We have an ongoing effort to update the
data under each category.
j) T2D-Db has 'save' options in every section of the data-
base. This option is helpful in saving the selected informa-
tion in a tab-delimited text file. The entire database
categorized into different data types, can be download
from the 'Downloads' section.
k) A separate section invites data updation from the users.
It provides a specific form (tab de-limited text) for each
data subset category that is required to be filled to upload
the data. T2D-Db team will validate the data and then
upload in the database.
Conclusion
Most of the candidate genes and chromosomal regions
have been studied individually and information on genet-
ics, molecular biology and biochemistry of each candidate
gene has been reported in the literature. An integrated,
curated and up to date resource bringing together all these
data is needed to facilitate the research on diabetes. The
user friendly web interface of T2D-Db helps users to
access the systematically organized data on almost all
molecular components reported in the literature. Since it
is the first attempt in the public domain to integrate the
data on molecular factors involved in T2DM, the database
is expected to serve as a unique repository and will be
highly useful to the diabetes research community world
wide.BMC Genomics 2008, 9:320 http://www.biomedcentral.com/1471-2164/9/320
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Screenshot of search results from a sample query showing microarray expression data for selected genes in T2D-Db (A-F) Figure 2
Screenshot of search results from a sample query showing microarray expression data for selected genes in 
T2D-Db (A-F). (A) Search page for entering the gene and/or organism name. (B) In the 'Search by Experiments' option, if the 
user selects an organism, the microarray experiment along with the corresponding genes present in the candidate gene list will 
be displayed. The user can also specify other genes in 'Add Gene(s)' section. (C) The user can search for patterns of gene 
expression present in multiple studies by using the 'Select by Genes across multiple experiments' option. Here on selecting the 
organism same kind of gene list will be displayed. (D) & (E) After submitting the query as mentioned in (B) and (C) output pages 
will be displayed, which contain the gene symbol, corresponding probe id and expression values across different samples for 
the corresponding selected genes. (F) Selection of desired gene entries and clicking on "Select gene(s) to view Heatmap" facili-
tates visualization of the heatmap to represent the expression pattern graphically. The red, green and yellow colours describe 
increased, no change and decreased expression respectively.
(A)
(B)
(C)
E
(F)
(E)
(D)BMC Genomics 2008, 9:320 http://www.biomedcentral.com/1471-2164/9/320
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Screenshot of a SNP marker search result page and SNP map Figure 3
Screenshot of a SNP marker search result page and SNP map. An output page of SNP marker search for chromo-
somal region (10000000–20000000) of human chromosome 1. The 'View Marker Map', shows the labelled and dynamic map of 
SNP markers and the corresponding genes in the selected chromosomal segment. Tabulated information is also available for all 
SNP markers and Genes found in that selected region. The chromosomal segment, SNP markers and genes in the map have 
external links to the UCSC browser, dbSNP and NCBI Entrez gene respectively.BMC Genomics 2008, 9:320 http://www.biomedcentral.com/1471-2164/9/320
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The protein-protein interaction map Figure 4
The protein-protein interaction map. The results page shows the protein-protein interaction map for the gene HNF1A. 
The interaction data from APID and PIP databases can be visualized separately. Clicking of the icon 'Network view' of either of 
the data sources (APID or PIP), the interaction map for the corresponding genes will appear on the cytoscape panel.BMC Genomics 2008, 9:320 http://www.biomedcentral.com/1471-2164/9/320
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The resource will be periodically updated with the further
enhanced features and information. We further intend to
develop a ranking scheme for the tissue specific expres-
sion values so that data from different sources can ration-
ally be presented. The microarray expression module
could to be integrated with programs, which can cluster,
rank and compare differentially expressed genes across
experiments. It is also proposed to implement tools,
which can track all the relevant genomic elements in a
selected chromosomal region (T2DM candidate region)
of an organism. T2D-Db aims to provide the published
information of the patients' clinical data.
Availability and requirements
Project name: T2D-Db.
Project home page: http://t2ddb.ibab.ac.in
Operating system: Platform independent
Programming languages: Java 2, CGI-Perl 5.8.8, MySQL
5.0.22, Apache HTTP server 2.2
Licence: GNU GPL, FreeBSD
For non-academic user: licence needed. Contact to the
corresponding author.
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